Laurus Labs

  • Market Cap: Mid Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE947Q01028
  • NSEID: LAURUSLABS
  • BSEID: 540222
INR
999.00
-1.2 (-0.12%)
BSENSE

Jan 28

BSE+NSE Vol: 20.14 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Cr
Consolidate Nine Monthly Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
5,001.33
3,833.66
3,601.16
4,659.65
3,510.74
3,401.58
1,992.58
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
5,001.33
3,833.66
3,601.16
4,659.65
3,510.74
3,401.58
1,992.58
Raw Material Cost
2,001.48
1,802.22
1,830.94
2,120.07
1,747.16
1,656.93
1,195.34
Purchase of Finished goods
124.32
83.05
70.16
150.84
89.40
58.97
14.63
(Increase) / Decrease In Stocks
-130.44
-189.97
-190.69
-191.17
-326.05
-185.47
-214.88
Employee Cost
659.60
541.82
478.82
446.37
372.15
320.28
256.73
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.01
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
1,080.77
961.86
875.92
826.89
602.36
472.38
371.51
Total Expenditure (Excl Depreciation)
3,735.73
3,198.98
3,065.15
3,353.00
2,485.02
2,323.09
1,623.34
Operating Profit (PBDIT) excl Other Income
1,265.60
634.68
536.01
1,306.65
1,025.72
1,078.49
369.24
Other Income
43.15
16.53
7.81
4.29
14.01
19.14
7.78
Operating Profit (PBDIT)
1,308.75
651.21
543.82
1,310.94
1,039.73
1,097.63
377.02
Interest
130.29
159.60
132.40
112.07
71.84
46.25
68.93
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
1,178.46
491.61
411.42
1,198.87
967.89
1,051.38
308.09
Depreciation
357.95
319.66
282.33
237.07
185.75
151.44
141.22
Profit Before Tax
820.51
171.95
129.09
961.80
782.14
899.94
166.87
Tax
212.57
51.41
36.20
272.40
181.61
213.04
21.75
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
607.94
120.54
92.89
689.40
600.53
686.90
145.13
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
607.94
120.54
92.89
689.40
600.53
686.90
145.13
Share in Profit of Associates
0.11
5.03
-5.64
-1.24
-0.02
0.00
0.00
Minority Interest
2.04
0.36
-1.91
-2.03
-1.05
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
609.65
124.65
84.94
687.13
597.02
686.90
145.13
Equity Capital
107.97
107.85
107.79
107.73
107.47
107.32
106.91
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
10.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
4.65
1.71
0.43
3.76
2.85
5.07
1.38
Operating Profit Margin (Excl OI)
25.31%
16.56%
14.88%
28.04%
29.22%
31.71%
18.53%
Gross Profit Margin
23.56%
12.82%
11.42%
25.73%
27.57%
30.91%
15.46%
PAT Margin
12.16%
3.14%
2.58%
14.8%
17.11%
20.19%
7.28%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2025 is 30.46% vs 6.46% in Dec 2024

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2025 is 389.09% vs 46.75% in Dec 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2025 is 99.41% vs 18.41% in Dec 2024

stock-summary

Interest

YoY Growth in nine months ended Dec 2025 is -18.36% vs 20.54% in Dec 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024

Compare Nine Monthly Results Of Laurus Labs With
Markets Mojo
Figures in Cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
5,001.33
0
5,001.33
Other Operating Income
0.00
0.00
0.00
Total Operating income
5,001.33
0
5,001.33
Raw Material Cost
2,001.48
0
2,001.48
Purchase of Finished goods
124.32
0
124.32
(Increase) / Decrease In Stocks
-130.44
0
-130.44
Employee Cost
659.60
0
659.60
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
1,080.77
0.00
1,080.77
Total Expenditure (Excl Depreciation)
3,735.73
0
3,735.73
Operating Profit (PBDIT) excl Other Income
1,265.60
0.00
1,265.60
Other Income
43.15
0
43.15
Operating Profit (PBDIT)
1,308.75
0
1,308.75
Interest
130.29
0
130.29
Exceptional Items
0.00
0
0.00
Gross Profit (PBDT)
1,178.46
0
1,178.46
Depreciation
357.95
0
357.95
Profit Before Tax
820.51
0
820.51
Tax
212.57
0
212.57
Provisions and contingencies
0.00
0
0.00
Profit After Tax
607.94
0
607.94
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
607.94
0
607.94
Share in Profit of Associates
0.11
0
0.11
Minority Interest
2.04
0
2.04
Other related items
0.00
0.00
0.00
Consolidated Net Profit
609.65
0
609.65
Equity Capital
107.97
0
107.97
Face Value
2.00
0
0.00
Reserves
0.00
0
0.00
Gross Profit Margin
23.56%
0.00%
0.00
23.56%
PAT Margin
12.16%
0.00%
0.00
12.16%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 5,001.33 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 30.46% vs 6.46% in Dec 2024

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 609.65 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 389.09% vs 46.75% in Dec 2024

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 1,265.60 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is 99.41% vs 18.41% in Dec 2024

Nine Monthly - Interest
Interest 130.29 Cr
in Dec 2025

Figures in Cr
stock-summary

YoY Growth in nine months ended Dec 2025 is -18.36% vs 20.54% in Dec 2024

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 25.31%
in Dec 2025

Figures in %
stock-summary

YoY Growth in nine months ended Dec 2025 has improved from Dec 2024